Honglei Jin

1.5k citations

43 papers · 1.1k indexed · h-index 21

Co-authors: Chuanshu Huang Haishan Huang Jingxia Li Junlan Zhu Guosong Jiang Xue‐Ru Wu Dongyun ZhangChao Huang
Topics: RNA modifications and cancer (15 papers)MicroRNA in disease regulation (10 papers)Ubiquitin and proteasome pathways (10 papers)
Cited by: Cancer Research Molecular Biology Geriatrics and Gerontology
Journals: Journal of Biological Chemistry Oncogene Biochemical Journal
Partner nations: China United States Italy

In The Last Decade

Honglei Jin

43 papers receiving 1.1k citations

Peers

Countries citing papers authored by Honglei Jin

Since Specialization

Citations

This map shows the geographic impact of Honglei Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Honglei Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Honglei Jin more than expected).

Fields of papers citing papers by Honglei Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Honglei Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Honglei Jin. The network helps show where Honglei Jin may publish in the future.

Co-authorship network of co-authors of Honglei Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Honglei Jin. A scholar is included among the top collaborators of Honglei Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Honglei Jin. Honglei Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	XIAP promotes metastasis of bladder cancer cells by ubiquitylating YTHDC1 2025 ·Cell Death and Disease ·Ning Sun,(unknown),(unknown),Peipei Zhang,Yi-Xin Chang,(unknown),Qiongyu Hao,Yijie Liu,Mingzhi Huang,(unknown),(unknown),Yongyong Lu,Guosong Jiang,Wei Chen,(unknown),Honglei Jin	2
2	TRIM40 interacts with ROCK1 directly and inhibits colorectal cancer cell proliferation through the c-Myc/p21 axis 2024 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·(unknown),Lingling Zhao,Junyu Wang,(unknown),(unknown),Yimeng Ma,(unknown),(unknown),(unknown),Xiaohuan Guo,(unknown),Honglei Jin,Qipeng Xie,Xiaodong Zhang,(unknown),Haishan Huang	2
3	CRTAC1 enhances the chemosensitivity of non-small cell lung cancer to cisplatin by eliciting RyR-mediated calcium release and inhibiting Akt1 expression 2023 ·Cell Death and Disease ·(unknown),Lingling Zhao,Yi-Xin Chang,(unknown),(unknown),Shuang Wu,(unknown),Yimeng Ma,(unknown),(unknown),Yuanyuan Chang,Honglei Jin,Qipeng Xie,(unknown),Haishan Huang	4
4	LINC00955 suppresses colorectal cancer growth by acting as a molecular scaffold of TRIM25 and Sp1 to Inhibit DNMT3B-mediated methylation of the PHIP promoter 2023 ·BMC Cancer ·(unknown),Hongyan Li,(unknown),(unknown),(unknown),Shuang Wu,(unknown),Honglei Jin,Lingling Zhao,Xiaodong Zhang,Dongxiang Liu,Chuanshu Huang,Haishan Huang	11
5	SNHG18 inhibits bladder cancer cell proliferation by increasing p21 transcription through destabilizing c-Myc protein 2023 ·Cancer Cell International ·(unknown),Ning Sun,(unknown),Peipei Zhang,(unknown),(unknown),Zhijian Zheng,Yongyong Lu,Honglei Jin	7
6	Integrated metabolomic and transcriptomic analyses reveal molecular response of anthocyanins biosynthesis in perilla to light intensity 2022 ·Frontiers in Plant Science ·(unknown),(unknown),(unknown),Duan Wu,(unknown),(unknown),Honglei Jin,Hongbin Wang,Qi Shen	13
7	uc.77- Downregulation Promotes Colorectal Cancer Cell Proliferation by Inhibiting FBXW8-Mediated CDK4 Protein Degradation 2021 ·Frontiers in Oncology ·Zhijian Zheng,(unknown),Xiaodong Zhang,Yi-Xin Chang,Ning Sun,(unknown),(unknown),Shirui Huang,Ruirui Zhang,Qipeng Xie,Haishan Huang,Honglei Jin	12
8	miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription 2019 ·Molecular Therapy ·Qipeng Xie,Caiyi Chen,Haiying Li,Jiheng Xu,Lei Wu,Yu Yuan,(unknown),(unknown),Xiaohui Hua,Huiying Yan,Dapang Rao,Huxiang Zhang,Honglei Jin,Haishan Huang,Chuanshu Huang	17
9	XIAP Interaction with E2F1 and Sp1 via its BIR2 and BIR3 domains specific activated MMP2 to promote bladder cancer invasion 2019 ·Oncogenesis ·Jiheng Xu,Xiaohui Hua,Rui Yang,Honglei Jin,Jingxia Li,Junlan Zhu,Zhongxian Tian,(unknown),Guosong Jiang,Haishan Huang,Chuanshu Huang	21
10	Transcriptionally elevation of miR-494 by new ChlA-F compound via a HuR/JunB axis inhibits human bladder cancer cell invasion 2019 ·Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms ·Zhongxian Tian,(unknown),Junlan Zhu,Xiaohui Hua,Jiheng Xu,Chao Huang,Honglei Jin,Haishan Huang,Chuanshu Huang	8
11	MEG3, as a Competing Endogenous RNA, Binds with miR-27a to Promote PHLPP2 Protein Translation and Impairs Bladder Cancer Invasion 2019 ·Molecular Therapy — Nucleic Acids ·Chao Huang,Xin Liao,Honglei Jin,Fei Xie,(unknown),Jingxia Li,(unknown),Guosong Jiang,Xue‐Ru Wu,Chuanshu Huang	46
12	New compound ChlA-F induces autophagy-dependent anti-cancer effect via upregulating Sestrin-2 in human bladder cancer 2018 ·Cancer Letters ·Xiaohui Hua,Jiheng Xu,Xu Deng,Jiawei Xu,Jingxia Li,(unknown),Junlan Zhu,Honglei Jin,Zhongxian Tian,Haishan Huang,Qin‐Shi Zhao,Chuanshu Huang	38
13	ISO, via Upregulating MiR-137 Transcription, Inhibits GSK3β-HSP70-MMP-2 Axis, Resulting in Attenuating Urothelial Cancer Invasion 2018 ·Molecular Therapy — Nucleic Acids ·(unknown),Haishan Huang,Honglei Jin,Jiheng Xu,Sanjiv Risal,Jingxia Li,Xin Li,Huiying Yan,Xingruo Zeng,Lei Xue,Changyan Chen,Chuanshu Huang	15
14	PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein 2018 ·Oncogene ·(unknown),Jingjing Wang,Dongyun Zhang,Honglei Jin,Jingxia Li,Xue‐Ru Wu,Chuanshu Huang	29
15	MicroRNA-411 Downregulation Enhances Tumor Growth by Upregulating MLLT11 Expression in Human Bladder Cancer 2018 ·Molecular Therapy — Nucleic Acids ·Honglei Jin,(unknown),(unknown),Huiying Yan,(unknown),Shuai Wang,Caiyi Chen,Jiayan Gu,Xiaohui Hua,Mengtao Zhou,Guosong Jiang,Dapang Rao,Qipeng Xie,Haishan Huang,Chuanshu Huang	34
16	XIAP BIR domain suppresses miR-200a expression and subsequently promotes EGFR protein translation and anchorage-independent growth of bladder cancer cell 2017 ·Journal of Hematology & Oncology ·Chao Huang,Xingruo Zeng,Guosong Jiang,Xin Liao,Claire Liu,Jingxia Li,Honglei Jin,Junlan Zhu,Hong Sun,Xue‐Ru Wu,Chuanshu Huang	33
17	ATG7 Overexpression Is Crucial for Tumorigenic Growth of Bladder Cancer In Vitro and In Vivo by Targeting the ETS2/miRNA196b/FOXO1/p27 Axis 2017 ·Molecular Therapy — Nucleic Acids ·Junlan Zhu,Yang Li,Zhongxian Tian,Xiaohui Hua,Jiayan Gu,Jingxia Li,Claire Liu,Honglei Jin,Yulei Wang,Guosong Jiang,Haishan Huang,Chuanshu Huang	52
18	Mitochondrial catalase induces cells transformation through nucleolin-dependent Cox-2 mRNA stabilization 2017 ·Free Radical Biology and Medicine ·Xin Liao,Chao Huang,Dongyun Zhang,Jingjing Wang,Jingxia Li,Honglei Jin,Chuanshu Huang	14
19	Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis 2016 ·Cancer Prevention Research ·Guosong Jiang,(unknown),Chao Huang,Jiayan Gu,Ping Zhang,Haishan Huang,Xin Liao,Jingxia Li,Dongyun Zhang,Xingruo Zeng,Honglei Jin,Haojie Huang,Chuanshu Huang	59
20	PHLPP2 Downregulation Contributes to Lung Carcinogenesis Following B[a]P/B[a]PDE Exposure 2015 ·Clinical Cancer Research ·Haishan Huang,Xiaofu Pan,Honglei Jin,Yang Li,Lin Zhang,Caili Yang,Pei Liu,Ya Liu,Lili Chen,Jingxia Li,Junlan Zhu,Xingruo Zeng,Kai Fu,Guorong Chen,Jimin Gao,Chuanshu Huang	54

About Honglei Jin

Honglei Jin is a scholar working on Cancer Research, Molecular Biology and Oncology, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), MicroRNA in disease regulation (10 papers) and Ubiquitin and proteasome pathways (10 papers). The work is most often cited by research in Cancer Research (467 citations), Molecular Biology (898 citations) and Geriatrics and Gerontology (29 citations). Honglei Jin has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Chuanshu Huang, Haishan Huang, Jingxia Li, Junlan Zhu, Guosong Jiang, Xue‐Ru Wu, Dongyun Zhang, Chao Huang, Jiheng Xu and Zhongxian Tian. Their work appears in journals such as Journal of Biological Chemistry, Oncogene and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact